Clinical trial
Health-Related Outcomes in Patients Who Were Previously Treated for…
NCT00003801 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003801 |
|---|---|
| Title | Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma |
| Official title | Intergroup Rhabdomyosarcoma Study Group: Late Effects After Treatment for Rhabdomyosarcoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Pediatric Oncology Group Children's Cancer Group |
| Status | Completed |
| Study type | Interventional |
| Conditions | Long-term Effects Secondary to Cancer Therapy in Children, Sarcoma |
| Intervention type | Procedure |
| Interventions | management of therapy complications, quality-of-life assessment |
| First posted | May 20, 2004 |
| Last update posted | Aug 20, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: